Chicago Capital’s Bristol-Myers Squibb BMY Stock Holding History

Chicago Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$648K	Hold	11,250	–	–	0.02%	251
2026 Q1	$682K	Sell	11,250 -320	-3%	-$18.7K	0.02%	238
2025 Q4	$624K	Buy	11,570 +405	+4%	+$19.5K	0.02%	236
2025 Q3	$504K	Hold	11,165	–	–	0.01%	244
2025 Q2	$517K	Sell	11,165 -97	-0.9%	-$4.76K	0.01%	248
2025 Q1	$687K	Hold	11,262	–	–	0.02%	211
2024 Q4	$637K	Sell	11,262 -1,275	-10%	-$71.2K	0.02%	204
2024 Q3	$649K	Sell	12,537 -1,484	-11%	-$69.6K	0.02%	203
2024 Q2	$582K	Sell	14,021 -1,775	-11%	-$79.4K	0.02%	209
2024 Q1	$857K	Sell	15,796 -499	-3%	-$25.4K	0.03%	172
2023 Q4	$836K	Sell	16,295 -11,495	-41%	-$603K	0.03%	163
2023 Q3	$1.61M	Sell	27,790 -298	-1%	-$18.3K	0.08%	81
2023 Q2	$1.8M	Sell	28,088 -5,425	-16%	-$364K	0.08%	79
2023 Q1	$2.32M	Sell	33,513 -75	-0.2%	-$5.29K	0.12%	75
2022 Q4	$2.42M	Hold	33,588	–	–	0.13%	77
2022 Q3	$2.39M	Buy	33,588 +15	+0%	+$1.09K	0.14%	73
2022 Q2	$2.58M	Sell	33,573 -500	-1%	-$38.1K	0.14%	74
2022 Q1	$2.49M	Sell	34,073 -420	-1%	-$28.2K	0.11%	77
2021 Q4	$2.15M	Hold	34,493	–	–	0.08%	84
2021 Q3	$2.04M	Sell	34,493 -1,000	-3%	-$65.9K	0.08%	85
2021 Q2	$2.37M	Sell	35,493 -1,440	-4%	-$93.9K	0.09%	78
2021 Q1	$2.33M	Buy	36,933 +2,259	+7%	+$141K	0.1%	78
2020 Q4	$2.15M	Sell	34,674 -302	-0.9%	-$18.6K	0.1%	78
2020 Q3	$2.11M	Hold	34,976	–	–	0.11%	80
2020 Q2	$2.06M	Hold	34,976	–	–	0.12%	81
2020 Q1	$1.95M	Hold	34,976	–	–	0.16%	72
2019 Q4	$2.25M	Buy	34,976 +3,421	+11%	+$196K	0.14%	76
2019 Q3	$1.6M	Buy	31,555 +35	+0.1%	+$1.65K	0.11%	87
2019 Q2	$1.43M	Sell	31,520 -1,133	-3%	-$52.8K	0.09%	93
2019 Q1	$1.56M	Buy	32,653 +1,043	+3%	+$52K	0.11%	88
2018 Q4	$1.64M	Hold	31,610	–	–	0.13%	76
2018 Q3	$1.96M	Sell	31,610 -1,400	-4%	-$83.1K	0.14%	72
2018 Q2	$1.83M	Buy	33,010 +12,333	+60%	+$666K	0.15%	77
2018 Q1	$1.31M	Buy	+20,677	New	+$1.33M	0.17%	71

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Chicago Capital's BMY Position: Q2 2026 in Review

Chicago Capital held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 11,250 shares worth $648K. The position accounts for 0.02% of the portfolio, ranked #251.

Chicago Capital first reported a position in BMY in Q1 2018 and has held it in 34 quarters since. The position peaked at $2.58M in Q2 2022. 917 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Chicago Capital held 11,250 shares of Bristol-Myers Squibb worth $648K as of Q2 2026.
Chicago Capital left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 0.02% of Chicago Capital's portfolio in Q2 2026, its #251 holding.
Chicago Capital first reported a position in Bristol-Myers Squibb in Q1 2018 and has held it in 34 quarters since.
Chicago Capital's Bristol-Myers Squibb position peaked at $2.58M in Q2 2022.
917 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Chicago Capital's 13F filing for Q2 2026, filed 28 Jul 2026.